Effects of metoprolol and carvedilol on cause-specific mortality and morbidity in patients with chronic heart failure--COMET.
暂无分享,去创建一个
P. Poole‐Wilson | K. Swedberg | J. Cleland | M. Metra | A. di Lenarda | M. Komajda | W. Remme | C. Torp-Pedersen | P. Hanrath | A. Scherhag | B. Lutiger | A. Skene | A. Di Lenarda
[1] M. Packer. Do β-blockers prolong survival in heart failure only by inhibiting the β1-receptor? A perspective on the results of the COMET trial , 2003 .
[2] F. Waagstein,et al. COMET: a proposed mechanism of action to explain the results and concerns about dose , 2003, The Lancet.
[3] P. Poole‐Wilson,et al. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial , 2003, The Lancet.
[4] D. DeMets,et al. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure: Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Study , 2002, Circulation.
[5] P. Poole‐Wilson,et al. Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET , 2002, European journal of heart failure.
[6] H. Krumholz,et al. β-Blocker Therapy in Heart Failure: Scientific Review , 2002 .
[7] M. Cucherat,et al. Bisoprolol for the treatment of chronic heart failure: a meta-analysis on individual data of two placebo-controlled studies--CIBIS and CIBIS II. Cardiac Insufficiency Bisoprolol Study. , 2002, American heart journal.
[8] Jan A Staessen,et al. Cardiovascular protection and blood pressure reduction: a meta-analysis , 2001, The Lancet.
[9] M. Domanski,et al. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. , 2001, The New England journal of medicine.
[10] D. DeMets,et al. Effect of carvedilol on survival in severe chronic heart failure. , 2001, The New England journal of medicine.
[11] L. Lind,et al. Effects Of Digoxin, Furosemide, Enalaprilat And Metoprolol On Endothelial Function In Young Normotensive Subjects , 2001, Clinical and experimental pharmacology & physiology.
[12] A. Mallet,et al. Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial , 2001, Circulation.
[13] K. Kanazawa,et al. Carvedilol improves endothelium-dependent dilatation in patients with coronary artery disease. , 2000, American heart journal.
[14] R Dietz,et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.
[15] Fach,et al. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) , 1999, The Lancet.
[16] H. Dargie,et al. The Cardiac Insufficiency Bisoprolol Study II , 1999, The Lancet.
[17] CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial , 1999, The Lancet.
[18] B. Andersson. 3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial , 1998, The Lancet.
[19] P. Lauriola,et al. Avoidable deaths from vehicle accidents in Modena, Italy , 1998, The Lancet.
[20] H. Elming,et al. Classification of Sudden and Arrhythmic Death , 1997, Pacing and clinical electrophysiology : PACE.
[21] C M O'Connor,et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. , 1996, The New England journal of medicine.
[22] A. Hall,et al. Mode of death in chronic heart failure. A request and proposition for more accurate classification. , 1996, European heart journal.
[23] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[24] L. Wilkins. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. , 1994, Circulation.
[25] K. Swedberg,et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy , 1993, The Lancet.
[26] H. Ikram,et al. Xamoterol in severe heart failure , 1990, The Lancet.
[27] K. Swedberg,et al. PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADE , 1979, The Lancet.
[28] E. Varnauskas,et al. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. , 1975, British heart journal.